title: [A study of the incidence and hospital follow-up of epistaxis in patients treated with anticoagulant acenocoumarol].
abstract: Nosebleed is a common reason for emergency ENT consultations, but it is infrequent in patients anticoagulated with acenocoumarol. In a retrospective 5-year study, nosebleed was the second most frequent type of hemorrhage among anticoagulated patients. Such patients do not necessarily have prolonged coagulation times. In a comparison of patients hospitalized for nosebleed (n = 14) with a similar group with no hemostasis abnormalities, patients with nosebleed had longer hospital stays and required more control measures. The greater the tendency to hypocoagulation, the more difficult it was to manage nosebleed. Recent onset of anticoagulation therapy and previous long coagulation times favored the appearance of hard-to-manage nosebleed. Therefore, hematologists should closely control patients under anticoagulation therapy and cooperate with the ENT department when such patients are admitted for nosebleed.
authors.affiliation: Servicio de ORL, Hospital Clínico Universitario, Valencia.
authors.forename: F J
authors.initials: FJ
authors.lastname: García Callejo
authors.forename: M M
authors.initials: MM
authors.lastname: Velert Vila
authors.forename: M H
authors.initials: MH
authors.lastname: Orts Alborch
authors.forename: R
authors.initials: R
authors.lastname: Monzó Gandía
authors.forename: L
authors.initials: L
authors.lastname: Pardo Mateu
authors.forename: F
authors.initials: F
authors.lastname: Rubio Escolano
authors.forename: J
authors.initials: J
authors.lastname: Marco Algarra
mesh_terms: D000074:Acenocoumarol / Q000009:adverse effects*; D000925:Anticoagulants / Q000009:adverse effects*; D004844:Epistaxis / Q000139:chemically induced* / Q000453:epidemiology* / Q000534:rehabilitation; D005260:Female; D005500:Follow-Up Studies; D006760:Hospitalization; D006801:Humans; D015994:Incidence; D008297:Male; D012189:Retrospective Studies
chemical_list: D000925:Anticoagulants; D000074:Acenocoumarol